抗甲状腺药物治疗Graves病复发影响因素的研究进展

Research Progress on Influencing Factors of Graves’ Disease Recurrence Treated with Antithyroid Drugs

Graves病(Graves Disease, GD)是常见的自身免疫性疾病(Autoimmune thyroid disease, AITD),目前尚无针对病因的治疗方法。通常情况下,抗甲状腺药物治疗(Antithyroid drugs, ATD)仍然使我国首选的治疗措施,但停药后复发风险高。GD多次复发不仅影响患者的工作和生活,也给临床医生的治疗带来挑战,因此明确影响复发的因素至关重要,有助于为治疗提供更精准的指导。本文就ATD治疗后GD复发的影响因素进行综述。

Graves Disease (GD) is a common Autoimmune thyroid disease (AITD), which currently has no treatment for the cause. Usually, Antithyroid drugs (ATD) remain the preferred treatment in China, but the risk of recurrence is high after withdrawal. Repeated recurrence of GD not only affects pa-tients’ work and life, but also brings challenges to the treatment of clinicians. Therefore, it is crucial to identify the factors affecting recurrence, which helps to provide more accurate guidance for treatment. This article reviews the factors affecting GD recurrence after ATD treatment.